Latest News

No benefit for post-operative radiotherapy in non-small-cell lung cancer



Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer.

Source link

Related posts

Trump wrongly said health insurers will pay for all coronavirus treatment

Newsemia

COVID-19 hotspots projected with new website

Newsemia

HCV-infected donor kidneys are safe and functional one year post-transplantation

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World